{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:42:56Z","timestamp":1790678576080,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.clinbiochem.2013.01.023","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T12:14:50Z","timestamp":1360066490000},"page":"701-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemia"],"prefix":"10.1016","volume":"46","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-xuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-zhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-qun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-chun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/asheducation-2011.1.36","article-title":"Impact of genetic features on treatment decisions in AML","volume":"2011","author":"D\u00f6hner","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0010","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2008"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0015","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/embor.2008.189","article-title":"The emerging role of splicing factors in cancer","volume":"9","author":"Grosso","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2012.09158.x","article-title":"Defects in spliceosomal machinery: a new pathway of leukaemogenesis","volume":"158","author":"Maciejewski","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0025","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0030","doi-asserted-by":"crossref","first-page":"e45760","DOI":"10.1371\/journal.pone.0045760","article-title":"U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"7","author":"Qian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0035","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0040","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","article-title":"Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes","volume":"119","author":"Damm","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V120.21.406.406","article-title":"SF3B1 mutations are detectable in 48.9% of acute myeloid leukemia with normal karyotype (AML-NK) and \u226515% ring sideroblasts and are closely related to FLT3-ITD and RUNX1 mutations","volume":"120","author":"Jeromin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2013.01.023_bb0050","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","article-title":"Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms","volume":"118","author":"Malcovati","year":"2011","journal-title":"Blood"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:40:24Z","timestamp":1757864424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":10,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0009912013000507"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.01.023","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}